+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Urinary Incontinence Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 400 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6100996
The urinary incontinence market was valued at USD 12.80 Billion in 2024, driven by the increasing prevalence of urinary incontinence across the 8 major markets. It is expected to grow at a CAGR of 6.40% during the forecast period of 2025-2034, and attain a market value of USD 23.80 Billion by 2034.

Urinary Incontinence Market Overview

Urinary incontinence is characterized by a loss of bladder control which can range from a slight loss of urine after coughing, sneezing, or laughing, to the complete loss of the ability to control urination. The growing aging population and the rising burden of chronic health conditions like diabetes, obesity, and neurological disorders are significant drivers of the market. Further, the rising development of wearable incontinence products equipped with leak-proof technology and high absorbency is likely to impact the market demand. Moreover, increasing investment in R&D and the growing emphasis on women's health are set to influence the market dynamics in the coming years.

Urinary Incontinence Market Growth Drivers

Increasing Cases of Urinary Incontinence to Drive Market Growth

Recent studies indicate that around 30-40% of women are affected by urinary incontinence at some point during their lifetime whereas 5-15% of men experience the condition in their lives. In India, it is estimated that up to 45% of women and 15% of men are living with some type of urinary incontinence. Further, the susceptibility to developing this health issue increases as people get older, with over 50% of women falling in the age category of 80 years and above affected by urinary incontinence. Thus, the increasing prevalence of this condition is poised to bolster the demand for urinary incontinence management solutions.

Urinary Incontinence Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Rising Investment in Innovative Therapies to Affect the Market Landscape Significantly

In June 2024, United Kingdom-based Amber Therapeutics, a medical technology company specializing in next-generation bioelectrical therapies, raised USD 100 million in a Series A financing round, with participation from key healthcare and technology investors in the United Kingdom and the United States. The funding will be used to advance the company’s fully implantable adaptive neuromodulation therapy indicated for women with mixed urinary incontinence, Amber-UI, towards Food and Drug Administration (FDA) regulatory approval. Such substantial investment initiatives are likely to boost market growth in the forecast period.

Regulatory Approval of Advanced Products Poised to Augment Urinary Incontinence Market Demand

In May 2024, Watkins-Conti Products, a women-focused healthcare company received the FDA approval for their self-administered, intravaginally inserted prescription device Yōni.Fit Bladder Support. It is intended for the temporary management of urine leakage as a result of stress urinary incontinence in women aged 18 years or older. The rise in the regulatory approval of such innovative products for urinary incontinence is set to augment the market demand.

Growing Focus on Comfortable and Discreet Products to Elevate the Urinary Incontinence Market Value

A significant market trend is the rising shift toward incontinence products that are more discreet, comfortable, and designed to resemble regular underwear or sanitary products. For instance, the demand for absorbent underwear that looks similar to regular briefs is increasing in the market as they offer confidence and dignity to users. In addition, the rising adoption of environmentally friendly incontinence products is projected to elevate the market value over the forecast period.

Advancements in Medical Devices to Boost Urinary Incontinence Market Size

The market is witnessing a growing interest in wearable technology for the management of urinary incontinence. The popularity of smart incontinence products that track urine loss and provide real-time data is increasing among patients as well as caregivers due to the ability of such devices to monitor incontinence episodes.

Urinary Incontinence Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Market Breakup by Product:

  • Urethral Catheters
  • Urinary Slings
  • Artificial Urinary Sphincters
  • Electrical Stimulation Devices
  • Others

Market Breakup by Incontinence Type:

  • Stress
  • Overflow
  • Functional
  • Urge
  • Mixed

Market Breakup by Age Group:

  • Pediatric
  • Adult
  • Geriatric

Market Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Others

Market Breakup by Region:

  • United States
  • EU-4 and the United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

Urinary Incontinence Market Share

The Incontinence Type Segment is Poised to Hold Substantial Market Share

Based on the incontinence type, the market is segmented into stress, overflow, functional, urge, and mixed. Stress incontinence is considered the most common type of urinary incontinence and is predominantly found in women. It occurs when physical activities such as coughing, sneezing, or heavy lifting lead to urine leakage. The prevalence of this condition is particularly high among aging populations and postpartum women. On the other hand, urge incontinence affects both men and women and is often linked with neurological disorders.

Urinary Incontinence Market Analysis by Region

The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States represents a major market for urinary incontinence which can be attributed to the increasing aging population and the growing demand for innovative incontinence products such as advanced absorbent devices and comfortable adult diapers. Further, the rising awareness about urinary incontinence and the availability of treatment options also support market growth in the region. Moreover, the presence of a well-established healthcare system and the increasing development of non-invasive therapies are poised to aid the market expansion in the country.

Leading Players in the Urinary Incontinence Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:

Kimberly-Clark Corporation

This American multinational consumer goods and personal care corporation, headquartered in Texas, United States, is a major player in the market. Depend, Poise and Plenitud are adult care brands under Kimberly-Clark Corporation and offer incontinence products such as adult diapers, underwear, and pads for both men and women.

SCA Group

SCA Group's hygiene and health division Essity has a robust portfolio of incontinence products, including pads, protective underwear, and skin care products. The company is focusing on using eco-friendly materials and is also exploring digital health solutions to improve patient outcomes.

Coloplast Corp.

Coloplast Corp., established in 1978, specializes in solutions designed for ostomy, continence, and interventional urology, among others. The company sells catheters, urine bags, and continence aids for both men and women. Coloplast also invests in digital health technologies, such as telemedicine platforms.

Other key players in the market include Boston Scientific Corporation, Medtronic plc, Convatec Group PLC, Astellas Pharma Inc., Pfizer Inc., and Hollister Incorporated.

Key Questions Answered in the Urinary Incontinence Market Report

  • What was the urinary incontinence market value in 2024?
  • What is the urinary incontinence market forecast outlook for 2025-2034?
  • What are the regional markets covered in the report?
  • What is market segmentation based on product?
  • What is the market breakup based on incontinence types?
  • What is the market breakup by age group?
  • Who are the major end users in the market?
  • What are the major factors aiding the urinary incontinence market demand?
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • Which regional market is expected to lead the market share in the forecast period?
  • Which country is expected to experience expedited growth during the forecast period?
  • How do the prevalence and incidence of urinary incontinence affect the market landscape?
  • What are the major urinary incontinence market trends?
  • How does the rise in the geriatric population impact the market size?
  • Which product will dominate the market share?
  • Which incontinence type is expected to have a high market value in the coming years?
  • Which age group will experience the highest demand in the market segment?
  • Which end user is projected to contribute to the highest market growth?
  • Who are the key players involved in the urinary incontinence market?
  • What is the patent landscape of the market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Urinary Incontinence Market Overview - 8 Major Markets
3.1 Urinary Incontinence Market Historical Value 2018-2024
3.2 Urinary Incontinence Market Forecast Value 2025-2034
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Urinary Incontinence Overview
5.1 Guidelines and Stages
5.2 Pathophysiology
5.3 Screening and Diagnosis
5.4 Treatment Pathway
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
6.3 Risk Assessment and Treatment Success Rate
7 Urinary Incontinence Market - Epidemiology Scenario and Forecast - 8 Major Markets
7.1 8MM Epidemiology Scenario Overview 2018-2034
7.2 Prevalence, by Country
7.2.1 United States
7.2.2 United Kingdom
7.2.3 EU4
7.2.4 India
7.2.5 Japan
7.3 Diagnosed Cases, by Country
7.3.1 United States
7.3.2 United Kingdom
7.3.3 EU4
7.3.4 India
7.3.5 Japan
7.4 Treatment Seeking Rate, by Country
7.4.1 United States
7.4.2 United Kingdom
7.4.3 EU4
7.4.4 India
7.4.5 Japan
8 Urinary Incontinence Market Landscape - 8 Major Markets
8.1 Urinary Incontinence Market: Developers Landscape
8.1.1 Analysis by Year of Establishment
8.1.2 Analysis by Company Size
8.1.3 Analysis by Region
8.2 Urinary Incontinence Market: Product Landscape
8.2.1 Analysis by Product
8.2.2 Analysis by Incontinence Type
9 Urinary Incontinence Market Challenges and Unmet Needs
9.1 Treatment Pathway Challenges
9.2 Compliance and Drop-Out Analysis
9.3 Awareness and Prevention Gaps
10 Cost of Treatment
11 Urinary Incontinence Market Dynamics
11.1 Market Drivers and Constraints
11.2 SWOT Analysis
11.2.1 Strengths
11.2.2 Weaknesses
11.2.3 Opportunities
11.2.4 Threats
11.3 PESTEL Analysis
11.3.1 Political
11.3.2 Economic
11.3.3 Social
11.3.4 Technological
11.3.5 Legal
11.3.6 Environment
11.4 Porter’s Five Forces Model
11.4.1 Bargaining Power of Suppliers
11.4.2 Bargaining Power of Buyers
11.4.3 Threat of New Entrants
11.4.4 Threat of Substitutes
11.4.5 Degree of Rivalry
11.5 Key Demand Indicators
11.6 Key Price Indicators
11.7 Industry Events, Initiatives, and Trends
11.8 Value Chain Analysis
12 Urinary Incontinence Market Segmentation 218-2034 - 8 Major Markets
12.1 Urinary Incontinence Market 2018-2034 by Product
12.1.1 Market Overview
12.1.2 Urethral Catheters
12.1.3 Urinary Slings
12.1.4 Artificial Urinary Sphincters
12.1.5 Electrical Stimulation Devices
12.1.6 Others
12.2 Urinary Incontinence Market 2018-2034 by Type
12.2.1 Market Overview
12.2.2 Stress
12.2.3 Overflow
12.2.4 Functional
12.2.5 Urge
12.2.6 Mixed
12.3 Urinary Incontinence Market 2018-2034 by Age Group
12.3.1 Market Overview
12.3.2 Pediatric
12.3.3 Adult
12.3.4 Geriatric
12.4 Urinary Incontinence Market 2018-2034 by End User
12.4.1 Market Overview
12.4.2 Hospitals and Clinics
12.4.3 Ambulatory Surgical Centers
12.4.4 Homecare Settings
12.4.5 Others
12.5 Urinary Incontinence Market 2018-2034 by Region
12.5.1 Market Overview
12.5.2 United States
12.5.3 EU-4 and the United Kingdom
12.5.3.1 Germany
12.5.3.2 France
12.5.3.3 Italy
12.5.3.4 Spain
12.5.3.5 United Kingdom
12.5.4 Japan
12.5.5 India
13 United States Urinary Incontinence Market 218-2034
13.1 United States Urinary Incontinence Market 2018-2034 by Product
13.1.1 Market Overview
13.1.2 Urethral Catheters
13.1.3 Urinary Slings
13.1.4 Artificial Urinary Sphincters
13.1.5 Electrical Stimulation Devices
13.1.6 Others
13.2 United States Urinary Incontinence Market 2018-2034 by Type
13.2.1 Market Overview
13.2.2 Stress
13.2.3 Overflow
13.2.4 Functional
13.2.5 Urge
13.2.6 Mixed
13.3 United States Urinary Incontinence Market 2018-2034 by Age Group
13.3.1 Market Overview
13.3.2 Pediatric
13.3.3 Adult
13.3.4 Geriatric
13.4 United States Urinary Incontinence Market 2018-2034 by End User
13.4.1 Market Overview
13.4.2 Hospitals and Clinics
13.4.3 Ambulatory Surgical Centers
13.4.4 Homecare Settings
13.4.5 Others
14 EU-4 and United Kingdom Urinary Incontinence Market 218-2034
14.1 EU-4 and United Kingdom Urinary Incontinence Market 2018-2034 by Product
14.1.1 Market Overview
14.1.2 Urethral Catheters
14.1.3 Urinary Slings
14.1.4 Artificial Urinary Sphincters
14.1.5 Electrical Stimulation Devices
14.1.6 Others
14.2 EU-4 and United Kingdom Urinary Incontinence Market 2018-2034 by Type
14.2.1 Market Overview
14.2.2 Stress
14.2.3 Overflow
14.2.4 Functional
14.2.5 Urge
14.2.6 Mixed
14.3 EU-4 and United Kingdom Urinary Incontinence Market 2018-2034 by Age Group
14.3.1 Market Overview
14.3.2 Pediatric
14.3.3 Adult
14.3.4 Geriatric
14.4 EU-4 and United Kingdom Urinary Incontinence Market 2018-2034 by End User
14.4.1 Market Overview
14.4.2 Hospitals and Clinics
14.4.3 Ambulatory Surgical Centers
14.4.4 Homecare Settings
14.4.5 Others
15 Japan Urinary Incontinence Market 218-2034
15.1 Japan Urinary Incontinence Market 2018-2034 by Product
15.1.1 Market Overview
15.1.2 Urethral Catheters
15.1.3 Urinary Slings
15.1.4 Artificial Urinary Sphincters
15.1.5 Electrical Stimulation Devices
15.1.6 Others
15.2 Japan Urinary Incontinence Market 2018-2034 by Type
15.2.1 Market Overview
15.2.2 Stress
15.2.3 Overflow
15.2.4 Functional
15.2.5 Urge
15.2.6 Mixed
15.3 Japan Urinary Incontinence Market 2018-2034 by Age Group
15.3.1 Market Overview
15.3.2 Pediatric
15.3.3 Adult
15.3.4 Geriatric
15.4 Japan Urinary Incontinence Market 2018-2034 by End User
15.4.1 Market Overview
15.4.2 Hospitals and Clinics
15.4.3 Ambulatory Surgical Centers
15.4.4 Homecare Settings
15.4.5 Others
16 India Urinary Incontinence Market 218-2034
16.1 India Urinary Incontinence Market 2018-2034 by Product
16.1.1 Market Overview
16.1.2 Urethral Catheters
16.1.3 Urinary Slings
16.1.4 Artificial Urinary Sphincters
16.1.5 Electrical Stimulation Devices
16.1.6 Others
16.2 India Urinary Incontinence Market 2018-2034 by Type
16.2.1 Market Overview
16.2.2 Stress
16.2.3 Overflow
16.2.4 Functional
16.2.5 Urge
16.2.6 Mixed
16.3 India Urinary Incontinence Market 2018-2034 by Age Group
16.3.1 Market Overview
16.3.2 Pediatric
16.3.3 Adult
16.3.4 Geriatric
16.4 India Urinary Incontinence Market 2018-2034 by End User
16.4.1 Market Overview
16.4.2 Hospitals and Clinics
16.4.3 Ambulatory Surgical Centers
16.4.4 Homecare Settings
16.4.5 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.2 US FDA
17.3 EU EMA
17.4 Japan PMDA
17.5 India CDSCO
17.6 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication Year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
19 Clinical Trials Analysis
19.1 Analysis by Trial Registration Year
19.2 Analysis by Trial Status
19.3 Analysis by Trial Phase
19.4 Analysis by Therapeutic Area
19.5 Analysis by Geography
20 Grants Analysis
20.1 Analysis by Year
20.2 Analysis by Amount Awarded
20.3 Analysis by Issuing Authority
20.4 Analysis by Grant Application
20.5 Analysis by Funding Institute
20.6 Analysis by NIH Departments
20.7 Analysis by Recipient Organization
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Drug Class of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Strategic Initiatives
22.1 Analysis by Partnership Instances
22.2 Analysis by Drug Class of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Market Share Analysis, By Region (Top 5 Companies)
23.2 Kimberly-Clark Corporation
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Company News and Developments
23.2.5 Certifications
23.3 SCA Group
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Company News and Developments
23.3.5 Certifications
23.4 Coloplast Corp.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Company News and Developments
23.4.5 Certifications
23.5 Boston Scientific Corporation
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Company News and Developments
23.5.5 Certifications
23.6 Medtronic plc
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Company News and Developments
23.6.5 Certifications
23.7 Convatec Group PLC
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Company News and Developments
23.7.5 Certifications
23.8 Hollister Incorporated
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Company News and Developments
23.8.5 Certifications
23.9 Astellas Pharma Inc.
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Company News and Developments
23.9.5 Certifications
23.10 Pfizer In
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Company News and Developments
23.10.5 Certifications
24 Urinary Incontinence Market - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Payment Methods (Additional Insight)
26.1 Government Funded
26.2 Private Insurance
26.3 Out-of-Pocket

Companies Mentioned

  • Kimberly-Clark Corporation
  • SCA Group
  • Coloplast Corp.

Table Information